Patents by Inventor Eldon Geisert

Eldon Geisert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds with increased specificity for the treatment of glioma
    Patent number: 9187449
    Abstract: Disclosed are compounds for the treatment of cancer. Compounds disclosed herein are particularly effective for the selective inhibition of glioma cells.
    Type: Grant
    Filed: March 25, 2014
    Date of Patent: November 17, 2015
    Assignee: The University of Tennessee Research Foundation
    Inventors: Duane D. Miller, Shivaputra Appanna Patil, Renukadevi Patil, Terreia Jones, Amira Ahmed, Likeselam Asres, Charles Ryan Yates, Eldon Geisert
  • COMPOUNDS WITH INCREASED SPECIFICITY FOR THE TREATMENT OF GLIOMA
    Publication number: 20140296286
    Abstract: Disclosed are compounds for the treatment of cancer. Compounds disclosed herein are particularly effective for the selective inhibition of glioma cells.
    Type: Application
    Filed: March 25, 2014
    Publication date: October 2, 2014
    Applicant: University of Tennessee Research Foundation
    Inventors: Duane D. Miller, Shivaputra Appanna Patil, Renukadevi Patil, Terreia Jones, Amira Ahmed, Likeselam Asres, Charles Ryan Yates, Eldon Geisert
  • Substituted Tetrahydroisoquinoline Compounds for Cancer Therapy
    Publication number: 20080033007
    Abstract: Disclosed are compounds that are effective for selectively killing cancer cells. Compounds have been demonstrated to be especially effective for killing glioma cells, while exhibiting low toxicity to normal cells.
    Type: Application
    Filed: April 18, 2007
    Publication date: February 7, 2008
    Inventors: Duane Miller, Eldon Geisert, Charles Yates, Renukadevi Patil, William Orr, XiangDi Wang, Fei Ma, Oleg Kirichenko
  • SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS, METHODS OF MAKING, AND THEIR USE
    Publication number: 20070270460
    Abstract: Disclosed are novel substituted tetrahydroisoquinoline compounds, pharmaceutical compositions containing the compounds, methods of making the compounds, and methods of using the compounds to destroy a target cell, such as a cancer cell, and to treat or prevent a cancerous condition.
    Type: Application
    Filed: July 9, 2007
    Publication date: November 22, 2007
    Inventors: Duane Miller, Eldon Geisert, Michael Mohler, Victor Nikulin, Oleg Kirichenko, Seoung Hong, Gyong Kang, Igor Rakov